Furthermore, rash induced by PD-1 blockade might be explained by disrupted regulatory T-cell(Treg)-mediate immunosuppression via PD-1 pathway modulation, as demonstrated in murine graft-versus-host-disease (GVHD) models. This evidence concerns the gene PDCD1 and graft versus host disease.